Overview
Mijung Kim practices practicing medicine in Daejeon, Republic of Korea.
Kim is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Peripheral Neuropathy, Breast Cancer, Neurotoxicity Syndromes, and Anal Cancer.
They are actively involved in clinical research, co-authoring 16 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mijung Kim
Is Mijung Kim a top-rated expert for Peripheral Neuropathy?
MediFind is an objective health platform that identifies experts based on real-world data. Mijung Kim is classified as an Advanced expert for Peripheral Neuropathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mijung Kim participate in research or clinical trials?
Yes. Mijung Kim has published 16 articles and abstracts on conditions like Peripheral Neuropathy. You can view a list of Mijung Kim's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Peripheral Neuropathy
- Experienced
- Anal CancerKim isExperienced. Learn about Anal Cancer.
- Breast CancerKim isExperienced. Learn about Breast Cancer.
- Neurotoxicity SyndromesKim isExperienced. Learn about Neurotoxicity Syndromes.